We are live on ! Find out more
HTGM

HTG Molecular Diagnostics

Delisted

HTGM was delisted on the 14th of June, 2023.

24 hedge funds and large institutions have $16.4M invested in HTG Molecular Diagnostics in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

502% more capital inflows, than outflows

Capital inflows: $3.78M | Capital outflows: $629K

150% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 4

10.93% more ownership

Funds ownership: 34.18% → 45.11% (+11%)

0% more funds holding

Funds holding: 24 → 24 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

Holders
24
Holders Change
–
Holders Change %
0%
% of All Funds
0.42%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
3
Increased
10
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

HTGM Hedge Fund Activity: Q2 2021 in Review

24 of the 5,771 institutional investors tracked by Wall St. Rank reported a position in HTG Molecular Diagnostics (HTGM) for Q2 2021, worth a combined $16.4M — up 47% from $11.2M a quarter earlier.

Fund positioning in HTGM was balanced in Q2 2021: 3 funds opened new positions, 3 closed out, 10 added to existing stakes and 4 trimmed.

The largest buyer was AIGH Capital Management, adding an estimated $1.71M. The largest seller was Renaissance Technologies, cutting an estimated $368K.

  • 24 institutional investors held HTG Molecular Diagnostics (HTGM) as of Q2 2021, unchanged from Q1 2021.
  • Funds reported $16.4M of HTG Molecular Diagnostics stock for Q2 2021, up 47% quarter-over-quarter.
  • 3 funds opened new HTG Molecular Diagnostics positions in Q2 2021 and 3 closed out, a net change of 0 holders.
  • The largest HTG Molecular Diagnostics buyer in Q2 2021 was AIGH Capital Management, an estimated $1.71M added.
  • The largest HTG Molecular Diagnostics seller in Q2 2021 was Renaissance Technologies, an estimated $368K sold.

Based on aggregated 13F filings for Q2 2021.